Results: The mean number of morbidities in the sample was 1.27 (SE±0.01). The overall age and sex standardised prevalence of multimorbidity was 35.7% (34.8% to 36.7%), with women having significantly higher prevalence of multimorbidity than men (41.5% vs 29.5%; p<0.001). Of those with multimorbidity, 64.6% (62.8% to 66.3%) were aged less than 60 years. Prevalence of multimorbidity was positively associated with age ( p for trend <0.001) and affluence (p for trend <0.001) and significantly greater in women at all ages compared with men. For each 5-year increment in age there was an approximate 20% greater risk of multimorbidity in both sexes (18% in women 95% CI 1.14 to 1.22 and 22% in men 95% CI 1.18 to 1.26). Increasing age, female gender, nonJavanese ethnicity, and high per-capital expenditure were all significantly associated with higher odds of multimorbidity. The combination of hypertension with cardiac diseases, hypercholesterolemia, arthritis, and uric acid/gout were the most commonly occurring disease pairs in both sexes.
INTRODUCTION
Multimorbidity, the simultaneous existence of two or more chronic health conditions within an individual, without a defining primary index disease, is increasingly becoming the norm rather than the exception, particularly in high-income countries. [1] [2] [3] It increases progressively with age, 2 4 and is associated with increased risk of premature mortality and reduced quality of life. 5 In addition to these significant individual-level issues, multimorbidity is associated with substantial societal costs due to increased healthcare utilisation, and the greater demands on the healthcare system that it creates. [6] [7] [8] [9] [10] Furthermore, the pharmacomanagement of multimorbidity is multifaceted, often requiring polypharmacy that in turn is associated with high rates of adverse complications. 8 11 Moreover, its clinical management is complex and in practice, hindered by the lack of specific guidelines for the management of patients with multiple chronic conditions. 12 Previously, the study of the burden of multimorbidity has largely been confined to developed countries due to the availability of relevant data with which to examine this issue. 13 However, there is increasing recognition that the burden of multimorbidity is of increasing importance to populations in lower and middle-income countries.
Strengths and limitations of this study
▪ This is the first study to examine the prevalence, pattern and socioeconomic correlates of multimorbidity among Indonesian adults using data from a large representative cross-sectional survey. ▪ In addition to informing on prevalence of morbidity we examined the age and gender patterns associated with the most frequently occurring combinations of chronic morbid conditions. ▪ Limitations of the study are the use of selfreported data and the restriction to a predefined set of morbidities. ▪ The cross-sectional nature of the study precluded any causal inference from being made.
Historically, the pattern of mortality in these countries has largely been dominated by communicable diseases; but, substantive successes in public health over the past several decades in these countries has led not only to marked gains in life expectancy but an increase in the prevalence of chronic conditions placing additional strain on healthcare systems that are ill-equipped for coping with the growing widespread demand for chronic disease care. [13] [14] [15] [16] [17] Indonesia, the world's fourth most populous nation, is in the midst of a profound demographic and epidemiological transition. 18 Recent studies have identified Indonesia's sizeable chronic disease burden but little is known regarding the pattern of multimorbidity in the population. 19 Although Indonesia has an extensive primary healthcare structure that is largely delivered through a network of community health centres (Puskesmas), auxiliary health centres (Pustu) and private medical practice, recent evidence suggests that the country has limited capacity in its public health system to cope with any further increases in healthcare demand. 20 The purpose of the current study is therefore to inform on the prevalence, patterns and risk factors associated with multimorbidity in the Indonesian population; such information is a vital pre-requisite for the design and implementation of an effective primary healthcare system that is capable of delivering a comprehensive continuum of care to patients with multiple morbidities.
METHODS

Data source
Data for this study are from the fourth wave of Indonesian Family Life Survey (IFLS-4). IFLS is an ongoing health and socioeconomic comprehensive longitudinal survey consisting of four waves, beginning in 1993 and collected information on individual, household and community level. The original sampling frame was based on households in 13 of the 27 Indonesian provinces, representing about 83% of the Indonesian population in 1993. 21 Briefly, IFLS-1 collected information from over 22 000 individuals living in 7224 households. These original households and their split-offs were followed in subsequent waves fielded in 1997/1998, 2000 and 2007/2008. The recontact rates for the target households were more than 90% in all follow-up surveys. Moreover, in IFLS-4, 90.6% of target households were successfully recontacted with the lowest recontact rate in Jakarta (80.3%). The fourth wave of the survey included 44 103 (51.0% female) individuals from 13 535 households from urban and rural locations. 21 The sampling and survey methods for the IFLS have been discussed in detail elsewhere. 21 The IFLS-4 data are open for public use after registration on their website (http://www.rand. org/labor/FLS/IFLS/ifls4.html).
IFLS-4 collected individual-level data on anthropometry, morbidity indicators, healthcare utilisation, health behaviours and household expenditure as well as information on questions related to chronic morbid conditions in participants aged 40 years and above. Hence, this analysis is limited to that age-group.
Measurements
For our analysis, multimorbidity was the primary outcome measure and was defined as the presence of two or more chronic conditions in individual respondents. 1 2 7 8 The individual morbidity status was ascertained either through active measurements, or through self-report or both. Active measurements were obtained by a qualified team of trained nurses for biophysical parameters namely anthropometry, blood pressure (BP) and total cholesterol levels. 21 Three BP measurements were obtained using Omron self-inflating sphygmomanometers with a digital read-out and total cholesterol was measured using Cardiochek PA system. 21 To determine the occurrence of self-reported chronic conditions respondents were asked the question "Has a doctor/ paramedic/nurse/midwife ever told you that you had following chronic conditions of diseases?" with response options: hypertension, diabetes, tuberculosis, asthma and other chronic lung diseases, cardiac diseases(heart attack/coronary heart disease/angina or other heart diseases), liver diseases, stroke, cancer or malignancies, arthritis/rheumatism, uric acid/gout, depression, vision and hearing abnormalities. Among respondents with no reported diabetes or heart problems, undiagnosed diabetes and heart problems were identified based on the number of affirmative responses to conditions symptomatic of the respective disease. 22 For diabetes, these were: (1) often wake up to urinate during the night, (2) a cut or wound takes a long time to heal and (3) often have headache when waking up in the morning. For heart problems, these were (1) ever felt pain on the left side of your chest, (2) ever felt chest pains when climbing upstairs or uphill, and (3) ever felt chest pains when being active or walking fast. Undiagnosed diabetes was defined as having all three symptoms; undiagnosed heart problem was defined as having at least two symptoms. Beside self-reported depression, presence of depression was quantitatively measured using a short version of the Centre for Epidemiologic Studies Depression Scale (CES-D); a series of 10 questions examining depression symptoms. In this study, the CES-D score was treated as a dichotomous categorical variable with a score of equal to or greater than 11 representing significant depressive symptoms. 23 Participants with a positive history of asthma and other chronic lung diseases were defined as having a chronic respiratory disease, while arthritis and rheumatism were grouped together as arthritis.
For this analysis, we included obesity (body mass index (BMI) ≥30 kg/m 2 ) and hypercholesterolemia (blood total cholesterol value >6.2 mmol/L as additional chronic morbidities based on anthropometric and biochemical measurements. Hypertensive status was ascertained based on self-report and the mean BP value of three measurements. Respondents were classified as hypertensive if they had a mean systolic BP ≥140 mm Hg and/or mean diastolic BP ≥90 mm Hg, or were currently taking hypertension medication. 24 Sociodemographic factors as individual level determinants were based on self-report and included age, gender, ethnicity ( Javanese, non-Javanese), household location (urban, rural), marital status(currently married, currently not married including unmarried, separated or divorced and widow(er)), education level (elementary education or less, high school completed, graduate and above), participants economic status ( per capita expenditure for consumption). Per capita expenditure, the measure of current or 'immediate' living standard rather than income, was considered as economic status due to the fact that expenditure is the preferred direct measure of welfare in developing countries. [25] [26] [27] [28] Monthly household expenditure for consumption include the following food items (rice, meat and fish, vegetables, cooking oil, granulated sugar), and non-food items (kerosene). For all of the analyses, per capita expenditure was entered as a log-transformed continuous variable to make the distribution more symmetrical and to reduce the effect of any outliers. Per-capita monthly expenditure was categorised to quintiles: q1 (lowest) to q5 (highest).
Statistical analysis
As the prevalence of multimorbidity varied substantially with age and sex, 1 we analysed the data stratified by age group (40-59 years and ≥60 years) and separately for men and women. Chronic conditions with prevalence estimates ≥1% were included in estimating multimorbidity prevalence across age groups and sex. The prevalence of multimorbidity was estimated in relation to all sociodemographic correlates. All prevalence measures were direct-standardised to the 2010 age and sex distribution of the Indonesia population (2010 Indonesian Census). 29 We applied non-parametric tests to test the differences in the mean number of morbidities across different sociodemographic covariates.
The most common clusters of chronic conditions were assessed by clustering the disease types per individual, then reporting the most common (frequencies) within dyads and triads, and also by estimating the prevalence of each cluster within the study population ( per 100 persons). Data were reported only for the top 10 frequently occurring combinations of chronic conditions in the sample. Ratios between observed versus expected (multimorbidity coefficients) were also calculated and are reported. 30 We used the χ 2 to test whether the observed prevalence of comorbidity dyad and triad were greater than would be expected if the diseases occurred independently. 31 Binary logistic regression was used to determine socioeconomic and demographic predictors of multimorbidity compared to zero or one morbid condition. Results are presented in terms of the adjusted OR (AOR) with 95% CIs. Multicollinearity for covariates was tested using the variance inflation factor and tolerance values, which were negative. Marginal statistics were computed to estimate the linear prediction of mean number of morbidities and probabilities of multimorbidity across age and sex categories. All analyses were performed using the inverse probability sampling weights. 21 For analysis involving complete cases only we used inverse probability weighted method and complete cases were weighted by the inverse of their probability of being a complete case. 32 Data were analysed using Stata software V.12.0 for Windows (StataCorp LP, College Station, Texas, USA) and p values of less than 0.05 were considered statistically significant.
RESULTS
Participant's characteristics
Of 11 712 participants aged 40 years or above interviewed in the survey, 2014 (17.5%) did not have complete information related to all chronic diseases and thus they were excluded from further analysis (figure 1). We analysed data from 9438 (51.6% women) respondents for whom complete information on all included chronic diseases were available. The respondents with complete information were on average 3 years younger than those with incomplete information (54.1 years vs 57.2 years; p<0.001). Participants with complete information were more likely to be female (AOR: 1.2; 95% CI 1.1 to 1.4), currently married (AOR: 1.3; 1.1 to 1.5), high school or above educated (AOR: 1.3; 1.2 to 1.5), from a rural area (AOR: 1.1; 1.0 to 1.2), and of Javanese ethnicity (AOR: 1.1; 1.0 to 1.3). However, respondents with complete information did not differ significantly from those with incomplete information in terms of per capita expenditure. Of those included in the analysis, more than half (53.5%) were of Javanese ethnicity, 57.8% were from rural areas, and 72% of respondents had attained an elementary level of education or less. Men and women did not differ significantly across different sociodemographic characteristics except for education and marital status (see online supplementary table S1).
Prevalence of chronic conditions and multimorbidity Hypertension, hypercholesterolaemia, cardiac diseases and arthritis were the most prevalent chronic morbidities affecting 10%-48% of the population. The distribution of these conditions varied across age and sex group (table 1). The overall prevalence of hypertension, hypercholesterolemia, cardiac diseases and arthritis in women were 52%, 20%, 14% and 12%, respectively, compared to 44%, 12%, 12.7% and 7.8%, in men. The majority of the chronic morbidities were significantly higher in the older (≥60 years) versus younger (40-59 years) individuals ( p<0.05).
The mean number of morbidities in the sample was 1.27 (SE±0.01) and again varied by age and sex (table 2) . Women had significantly higher number of morbidities compared to men (1.50 vs 1.15; p<0.001)). The overall age and sex standardised prevalence of multimorbidity was 35.7% (95% CI 34.8% to 36.7%) with women having significantly higher prevalence of multimorbidity than men both overall (41.5% v 29.5%; p<0.001) and at all ages ( figure 2 and table 2 ). Of the people with at least one morbidity, 48.8% (47.5% to 50.1%) had multimorbidity. The number of morbidities and the proportion of people with multimorbidity showed a linear trend with increasing age (see online supplementary figure S1); each 5-year increment in age was associated with approximately 20% greater risk of multimorbidity in men and women. The mean number of chronic conditions was significantly higher in people of non-Javanese ethnicity (1.37 vs 1.27; p=<0.001) compared with Javanese ethnicity, who lived in urban compared with rural areas (1.48 vs 1.17; p<0.001), who had the highest per capita expenditure versus the lowest ( p<0.001), and with educational attainment ( p for trend <0.001). Table 3 shows the results of multivariable multinomial logistic regression of factors associated with multimorbidity. Increasing age, female gender, non-Javanese ethnicity and high per-capital expenditure were all significantly associated with higher odds of multimorbidity. Higher education status was significantly correlated with higher odds of multimorbidity but only in men. Women younger than 70 years of age had significantly higher odds of multimorbidity relative to men (figure 3). Figure 4 presents the leading five most frequently occurring morbidity dyads and triads among respondents with multimorbidity. The details of observed and expected prevalence rates for these combinations and multimorbidity coefficients (observed/expected ratio) are presented in the appendix (see online supplementary tables S2-S5). Most of the disease combinations were identified as the most prevalent conditions in table 1. The combination of hypertension with cardiac diseases, hypercholesterolaemia, arthritis and uric acid/gout were the most commonly occurring dyads in both sexes. The majority of these combinations showed statistically significantly higher observed prevalence than would be expected at random. The most prevalent individual disease conditions such as hypertension, hypercholesterolaemia, prevalent cardiac diseases and arthritis dominated the most frequent triad combinations. These four conditions, together with diabetes mellitus, uric acid/ gout, chronic respiratory diseases, obesity and vision abnormalities, were the main components of the 10 most prevalent triads across age groups with minimal differences between the sexes.
Common multimorbidity combinations
DISCUSSION
This study is the first to report on the population prevalence of multimorbidity in the Indonesian adult population using subnational data from the Indonesia Family Life Survey (IFLS-4). More than a third of adults over 40 years of age and half of individuals above 60 years had multimorbidity, but the pattern varied markedly across different sociodemographic characteristics. Increasing age, female gender, high per-capita household expenditure and urban locality were significant predictors of multimorbidity status.
In the current study, the prevalence of hypertension as well as self-reported cardiac diseases and diabetes was comparable with previous estimates that have been reported using nationally representative data. [33] [34] [35] [36] [37] The prevalence of obesity was, however, lower than in earlier reports although this is likely to be due in part to the lower cut-point for BMI used to define obesity in those studies. 37 With respect to the prevalence of other major chronic conditions including hypertension, hypercholesterolaemia and diabetes our findings are comparable with age and sex specific prevalence estimates reported in geographically and economically similar Asian countries such as Malaysia, Thailand and the Philippines. 38 Our findings demonstrate that the most commonly occurring comorbidities, were hypertension, prevalent cardiac diseases, arthritis, and hypercholesterolaemia together with vision abnormality and obesity. Similar combinations of prevalent cardiometabolic morbidities have also been reported by the recent systematic-reviews. 39 Stratifying the population by age and sex did not materially alter our results, although some interesting patterns were noted. For example, the most frequently occurring dyad (which comprised hypertension and hypercholesterolaemia) occurred with a frequency of 11% indicating that there is no dominant combination of morbid conditions that affects the population. From a public health perspective, this is challenging and requires development of comprehensive and contextualised clinical practice guidelines offering clinical management and treatment decision support for patients with multiple chronic diseases. 40 It is difficult to directly compare our findings with those from previous studies due to differences in study methodology including in how multimorbidity was defined 7 31 However, systematic reviews of studies have indicated a prevalence rate of multimorbidity ranging from less than 5% to more than 90%, with notable Figure 2 The proportion of population with number of chronic condition or morbidities according to age groups and gender. *Overall difference between men and women were significant at P value <0.001.
differences across different age groups and study settings. 7 41 A recent study analysing data from six lowerincome and middle-income countries also reported the multimorbidity prevalence to range from about 4-34%. 42 In line with earlier studies, we observed the prevalence of multimorbidity to increase with age and was higher among those living in urban areas. 1 7 14 42-44 However, due to the age distribution of the population the absolute burden of multimorbidity was greater among those under 60 years of age in whom two-thirds had the condition, consistent with previous observations that multimorbidity represents a significant health challenge to younger as well as older populations. 45 In agreement with previous studies, 1 2 16 42 43 we observed women to be more vulnerable to multimorbidity compared to men. And as in other lower-income and middle-income countries undergoing an epidemiological transition, 46 the prevalence of multimorbidity increased with greater affluence which is in contrast to the situation in higher-income countries where the least economically advantaged are typically at greatest risk of multimorbidity. 1 14 15 42 It is possible, however, that this discrepancy may be explained by respondents from lower socioeconomic background being less likely to report their health condition either due to limited access to healthcare or under diagnosis. 47 We also observed people of Javanese ethnicity to have a lower prevalence of multimorbidity compared to other ethnicities which may reflect differences in socioeconomic position.
A major strength of this study was the large randomly selected representative sample of Indonesian population which allows for greater generalisation of results. Population-based prevalence estimates of multimorbidity are essential for understanding the true health status of the community. However, there are some significant study limitations. The cross-sectional nature of the study did not permit any causal inferences to be made. We may have underestimated the prevalence of multimorbidity, since only 15 chronic conditions were included in the survey and the outcome was based on self-report, which may have introduced some misclassification bias. Nevertheless, this type of misclassification is likely to have been at random. We performed a complete case analysis which has the potential to introduce attrition bias if the excluded individuals are systematically different from those included. However, we used inverse probability weighted method to directly analyse only the complete cases with special weights assigned to those cases based on estimated probabilities of completeness, thereby minimising the possibility of attrition bias. 32 48 Moreover, the proportion of missing data was small and the prevalence of individual diseases did not vary significantly across participants with complete and incomplete information. The measure of multimorbidity was only concerned with the number of diseases and did not take into consideration the intensity or severity of disease nor did it take into account any undiagnosed chronic ailment. Moreover, the present study included obesity as a chronic condition, which has been previously been considered to be only a risk factor for multimorbidity, rather than a disease entity. [49] [50] [51] However, recent systematic reviews have shown obesity to be an independent predictor of patterns of multimorbidity, thereby creating an evidence-base for obesity to be included as a morbid condition. 13 52 Lastly, we used observed-to-expected ratios to analyse multimorbidity pattern, which apart from the technical difficulties implicit to the extraordinary numbers of theoretically possible combinations of diseases, depend on the prevalence of the individual diseases and do not adequately adjust for chance multimorbidity when non-random multimorbidity exists. 39 In summary, multimorbidity affects more than one-third of the Indonesian adult population with a greater absolute burden occurring in younger individuals and in women. Hypertension was almost integral to all patterns of multimorbidity at all ages indicating that effective interventions to reduce mean population BP should be given high priority in the Indonesian population. The recent comprehensive review on health system issues on managing non-communicable diseases (NCD) in the Asia-Pacific region highlighted a shortage of adequately trained health workers to manage NCDs; a lack of investment in training in the management of chronic diseases; weak health information systems that lack integrated and coordinated collection of data on chronic diseases; and unsuitable service delivery models for the continuum of care required for chronic diseases. 53 A comprehensive generalist care approach that is mainly, but not exclusive to primary care, has been suggested to be the most suitable strategy for the management of patients with multimorbidity. 1 44 However, the delivery of primary healthcare in Indonesia is principally built around the management of single diseases and therefore a greater focus on the development of contextualised treatment protocols for the management of comorbid conditions is needed. Indonesia has adopted the WHO Package of essential non-communicable disease interventions (WHO PEN) for primary healthcare in lowresource settings. 54 However, it is still at an early stage of implementation and requires scaling-up at the national level. Given the paucity of data on the predictors and patterns of multimorbidity in low and middle income countries, 13 41 findings from the current study are timely and provide novel insights into the burden of multimorbidity in these countries. However, further research is needed to understand how multimorbidity impacts healthcare utilisation and healthcare costs particularly in these low-resource settings.
